Effectiveness of Chaihu-Shugan-San in treatment of Non-alcoholic Fatty Liver Disease: A meta-analysis
Year: 2021
Type: report
Abstract: Review question / Objective: This study is to systematically evaluate the efficacy and safety of Chaihu-Shugan-San combined with or without conventional treatment for nonalcoholic fatty liver disease (NAFLD) was evaluated by metaanalysis.Condition being studied: Non-alcoholic fatty liver disease (NAFLD) has become the most important chronic liver disease, affecting approximately 1.7 billion people worldwide, accounting for approximately 25% of the adult population.Studies have shown that it is closely associated with extrahepatic tumors, diabetes, cardiovascular disease, and metabolic syndrome.Finding an effective and safe interventional therapy is urgent because there is no specific treatment method yet.Recent studies have found that Traditional Chinese medicine has prominent advantages in the treatment of NAFLD.INPLASY registration number: This protocol was registered with the International Platform of Registered Systematic Review and Meta-Analysis Protocols (INPLASY) on 20 October 2021 and was last updated on 20 October 2021 (registration number INPLASY2021100074).
Authors: Hui Chen, Xinyu Liu, Zhenzhen Meng, Xiaoqiang Huang, Shanghua Piao, Jiao Guo
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W3206086467